Cash-flow analysis for the
Catastrophic Expenses Fund
María-Cristina Gutiérrez-Delgado
Economic Analysis Unit,
Mexican Ministry of Health
Second International Colloquium Dresden, April 2004.
Contents.
• Background.
• Reform to the Mexican General Health Law.
• The Catastrophic Expenses Fund.
• Results, conclusions and recommendations.
• Next steps.
Background.
The Mexican health system.
Private sector Middle class Poor Urban/Rural Public Private
Functions
Provision Financing Stewardship Non-salaried workers in informal sectorPopulation groups
Federal and state Social Security IMSS ISSSTE Salaried workers in formal sectorFinancial characteristics.
• 1. Level: insufficient investment (5.8% of GDP)
• 2. Source: predominance of out-of-pocket payments (55%) • 3. Distribution
– Among populations: 1.7 times between insured and uninsured
– Among states: 7 to 1 between the state with the highest expenditure on the insured and the one with the lowest on the uninsured
• 4. State contributions: 109 to 1
• 5. Allocation items: payroll expenditure vs. investment
Distribution of healthcare expenditure.
42%
3%
55%
Public Out-of-pocket Pre-paid services Federal Gv´t State Gv´t Social Security Uninsured 31.8% 6.6% 61.6% 31.8% 61.6%Reform to the General Health Law.
System of Social Protection in Health.
Aims
• Offer financial protection to uninsured through a
public healthcare insurance scheme.
• Promote a culture of pre-payment among uninsured.
• Strengthen a culture of preventive healthcare.
• Decrease the number of uninsured families facing poverty
because of healthcare costs at point of delivery.
System of Social Protection in Health.
Healthcare goods and funds.
Personal health services (Popular Health Insurance) Public health goods
Budget of the Federal Ministry of Health Catastrophic Expenses Fund Personal Health Services Fund Community Health Services Fund
Funds
•Catastrophic interventions •Essential health interventions •Stewardship function•Information, research &
human resources development
•Community health
services
Structure of Financial Contributions.
Universal Health Insurance.
Source: Mexican Ministry of Health,2003. **Proposal for future reform to ISSSTE Law.
Popular Health Insurance, SSPH
(informal sector,
self-employed and unself-employed)
ISSSTE (public-sector salaried employees) ** IMSS (private-sector salaried employees) Federal Government (social contribution) State Gov´t Public employer Contributors Public Insurance Scheme Federal Gov´t Employee Employee Family Private employer Federal government (social contribution) Federal government (social contribution) solidarity contribution
Structure of Financial Contributions.
SSPH.
Social Contribution Federal Solidarity Contribution State Solidarity Contribution Contributions to SSPH: USD$675.52 per family during 200489 %
USD$675.52
USD$601.21 Personal Health Services 8 %
3 %
USD$ 54.04 Catastrophic Expenses
USD$ 20.27 Annual budget reserve
Family Contribution
Operative
reserve for drugs and medical material necessary for essential interventions According to socioeconomic conditions
The Catastrophic Expenses Fund.
Source: Mexican Ministry of Health,2003.
Aim
Purchasing of covered catastrophic expenses.
Catastrophic expenses
Those derived from the treatment of diseases which pose a
financial burden to the SSPH.
Coverage of catastrophic expenses will be gradual
following criteria defined in the General Health Law.
Diseases or treatments that
generate catastrophic expenses.
The General Health Council is responsible for the identification of diseases, definition of treatments and drugs that generate catastrophic expenses for the SSPH.
Total
Dialysis
Transplants
Neonatal intensive care Rehabilitation
Category
Injuries HIV/AIDS Neuro-vascular Cardio-vascular CancerCategory
5 1 3 2 12,8No.
53 2 6 8 6No.
Financial cash-flow.
CEF
Covered
Services
Interest Balance of annual budget reserve atend of tax year
Cash in-flow
(income)
Payment to authorized providers (Operative expenses)Cash out-flow
(expenses)
Administrative expenses 8% of Federal & States contributionsFinancial sufficiency.
How many diseases or treatments can
be covered with available resources?
• Short and mid-term financial sustainability.
• Selection of diseases, based on budgetary
resources, cost-effectiveness, infrastructure and
national healthcare priorities, is responsibility of
the National Commission of Social Protection in
Health.
Available information.
Set 4 plus bone marrow transplant. 5
Set 1: 2004; Set 2: 2005; Set 3: 2006; Set 4: 2009; Set 5: 2010.
6
Set 3 plus kidney transplant. 4
Set 2 plus breast cancer. 3
Set 1 plus acute myocardial infarctation. 2
HIV/AIDS, acute lymphoblastic leukemia, cervix-uterine cancer.
1
Disease or treatment
Set
Available information.
Short & mid-term projections.
Biometric: Target population; affiliation rates; incidence rates; mortality rates not included.
Financial: Minimum daily wage, interest rates; inflation rates.
Expenses: Annual number of cases per disease/treatment; annual average cost per case; annual
administrative expenses; quarterly payment. Income: Quarterly budget income; interest accrued
quarterly; balance of annual budget reserve at end of tax year.
Results under initial assumptions.
Paquete 1 -5 10 15 2004 2005 2006 2007 2008 2009 2010Miles de millones de pesos
Año Acumulado Gasto Paquete 4 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 3 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 5 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 6 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 2 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año
Acumulado Gasto
Results discounting the inflation effect.
Paquete 1 -5 10 15 2004 2005 2006 2007 2008 2009 2010Miles de millones de pesos
Año Acumulado Gasto Paquete 4 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 3 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 5 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 6 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 2 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año
Acumulado Gasto
Results under decrease of annual
average cost per case.
Paquete 1 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 4 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 3 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 5 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 6 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 2 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año
Acumulado Gasto
Results under increase of annual
average cost per case.
Paquete 1 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 4 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 3 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 5 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 6 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año Acumulado Gasto Paquete 2 -5 10 15 2004 2005 2006 2007 2008 2009 2010
Miles de millones de pesos
Año
Acumulado Gasto
Conclusions and recommendations.
• Key factor for sufficiency is the initial number of
diseases or interventions to be covered.
• Second most important factor is annual average cost
per case.
• Ratio between general and medical services inflation
rates is very important.
• Increases in target population show little impact in
cash-flow, but might become important once the
“universal coverage” is attained.
• Results help recommending to policy-makers starting
operations with most conservative set.
• Annual evaluation of CEF performance for
Next steps
• Incidence and prevalence rates among target population for
the 53 diseases?
• Mortality rates among target population for the 53 diseases? • Cost of treatment for the 53 diseases?
• Risk premiums for the 53 diseases? • Operative reserve for the CEF?